• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Glenmark Pharma > December 08, 2010

      Glenmark gets US FDA nod to sell painkiller drug in US

      Posted AtFinancialexpress.com

      New DelhiDrug maker Glenmark today said it along with its US-based partner has got the US health regulator's nod to manufacture and market two oxycodone products, used for treating moderate to severe pain, in the American market.

      The company's US arm, Glenmark Generics Inc and Lehigh Valley Technologies (LVT) have received US Food and Drug Administration nod for Oxycodone immediate release capsules, the company said in a filing to the Bombay Stock Exchange.

      The approval is for 5 mg capsule and 100 mg/5 ml oral solution, it said, adding, Glenmark Generics Inc and LVT have also signed a new supply and marketing agreement.

      Under the terms of agreement, LVT will be responsible for manufacturing of the Oxycodone product line for Glenmark's exclusive marketing and distribution in the generic form, the company said.

      "LVT would retain exclusive marketing rights to the branded version of the Oxycodone product line," it added. Further, the US firm will also retain exclusive marketing rights to additional strengths of Oxycodone product line in both generic and branded forms.

      According to market research firm IMS health, Oxycodone Hydrochloride immediate release capsule and liquid formulations had total market sales of USD 13 million for the 12 months ended September 2010.

      Shares of Glenmark Pharmaceuticals were today trading at Rs 382.10 on the BSE in the late afternoon trade, up 2.25 per cent from its previous close.

      December 08, 2010


       

      Share this Article!

    Back to top^